Overview
Law360 covered Steptoe's Federal Circuit success for Aquestive in an article titled "Full Fed. Circ. Won't Eye PTAB Order Junking Suboxone IPRs." On January 13, the Federal Circuit refused to revisit an earlier ruling that upheld a Patent Trial and Appeal Board (PTAB) decision denying inter partes review of Aquestive Therapeutics' patent on a dissolving drug delivery film. The full circuit court denied a rehearing petition by BioDelivery Sciences International Inc., which had argued that a split panel in August incorrectly dismissed its appeal of the PTAB's decision.
Steptoe intellectual property partners John Abramic and Jamie Lucia represent Aquestive along with associate Kate Cappaert.
The full article can be read at Law360 (subscription required).
